You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 163 No. 21, November 24, 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Investigation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (43)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Thrombolysis
 •Venous Thromboembolism
 •Quality of Care, Other
 •Randomized Controlled Trial
 •Alert me on articles by topic

Comparison of the Quality of Oral Anticoagulant Therapy Through Patient Self-management and Management by Specialized Anticoagulation Clinics in the Netherlands

A Randomized Clinical Trial

A. P. A. Gadisseur, MD; W. G. M. Breukink-Engbers, MD; F. J. M. van der Meer, MD, PhD; A. M. H. van den Besselaar, MD, PhD; A. Sturk, MSc, PhD; F. R. Rosendaal, MD, PhD

Arch Intern Med. 2003;163:2639-2646.

Background  Several studies have demonstrated that patient self-management of oral anticoagulant therapy (OAT) can improve treatment quality. However, most of these studies were not conducted within a specialized anticoagulation care system. The objective of the present study was to determine whether patient self-management of OAT improves the quality of care delivered by anticoagulation clinics.

Methods  In this randomized study by 2 Dutch anticoagulation clinics 341 patients aged between 18 and 75 years and receiving long-term OAT were divided into 4 groups: an existing routine care group of patients untrained in self-management; a routine care group of trained patients; a group managed weekly at an anticoagulation clinic where international normalized ratios were measured by trained patients; and weekly patient self-management. A 2-step randomization procedure was followed: first, a Zelen-design randomization was performed to distribute patients (without informing them) to the existing care group or to receive training in self-management; second, trained patients were randomized to the 3 other study groups.

Results  Only 25.6% of invited patients agreed to participate in the training program. Patients who remained in the existing care group were within the international normalized ratio target range 63.5% of the time. The type of coumarin taken was a major predicting factor of OAT quality. In all study groups phenprocoumon outperformed acenocoumarol by 11.6% (95% confidence interval [CI], 6.6%-16.5%). Weekly management with phenprocoumon led to a 6.5% improvement (95% CI, 0.0%-13.1%) in time in the international normalized ratio target range when patients were managed at an anticoagulation clinic and to an 8.7% improvement (95% CI, 1.6%-15.9%) when patients were self-managed. Weekly management with acenocoumarol did not improve the quality of OAT.

Conclusion  With selected patients, the quality of OAT obtained through patient self-management is at least as high as that delivered by specialized physicians at anticoagulation clinics. Weekly management of OAT with long-acting phenprocoumon has to be preferred at anticoagulation clinics or, where possible, through patient self-management.


From the Departments of Hematology/Hemostasis and Thrombosis Research Center (Drs Gadisseur, van der Meer, van den Besselaar, and Rosendaal) and Clinical Epidemiology (Dr Rosendaal), Leiden University Medical Center, Leiden, the Netherlands; the Leiden Anticoagulation Clinic, Leiden (Drs Gadisseur and van der Meer); the Oost-Gelderland Anticoagulation Clinic, Lichtenvoorde, the Netherlands (Dr Breukink-Engbers); and the Federation of Dutch Anticoagulation Clinics, Voorschoten, the Netherlands (Drs Breukink-Engbers and Sturk).The authors have no relevant financial interest in this article.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Anticoagulants in heart disease: current status and perspectives
De Caterina et al.
Eur Heart J 2007;0:ehl492v1-34.
FULL TEXT  

Effect of Study Setting on Anticoagulation Control: A Systematic Review and Metaregression
van Walraven et al.
Chest 2006;129:1155-1166.
ABSTRACT | FULL TEXT  

The Belgian Improvement Study on Oral Anticoagulation Therapy: a randomized clinical trial
Claes et al.
Eur Heart J 2005;26:2159-2165.
ABSTRACT | FULL TEXT  

Coagulation Assays
Bates and Weitz
Circulation 2005;112:e53-e60.
FULL TEXT  

Ximelagatran vs Warfarin for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation: A Randomized Trial
SPORTIF Executive Steering Committee for the SPORT
JAMA 2005;293:690-698.
ABSTRACT | FULL TEXT  

Comparing Self-Management of Oral Anticoagulant Therapy with Clinic Management: A Randomized Trial
Menendez-Jandula et al.
ANN INTERN MED 2005;142:1-10.
ABSTRACT | FULL TEXT  

Patient Self-Management of Anticoagulation: An Idea Whose Time Has Come
Beyth
ANN INTERN MED 2005;142:73-74.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.